Chinese Drugmaker Asymchem Slips in Hong Kong Trading Debut

Bloomberg2021-12-10

(Bloomberg) -- Chinese contract drug manufacturer Asymchem Laboratories Tianjin Co. dropped in its first day of trading in Hong Kong, after completing the Asian financial hub’s biggest initial public ...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

rustic
2021-12-10
rustic
Ok
- Bubble5728:
  Ok

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/1118435301?lang=zh_CN&edition=full","thumbnail":"","is_english":true,"pubTime":"2021-12-10 10:55","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1118435301","market":"hk","top_or_hot":-1,"title":"Chinese Drugmaker Asymchem Slips in Hong Kong Trading Debut","media":"Bloomberg","content":"<div>\n<p>(Bloomberg) -- Chinese contract drug manufacturer Asymchem Laboratories Tianjin Co. dropped in its first day of trading in Hong Kong, after completing the Asian financial hub’s biggest initial public ...</p>\n\n<a href=\"https://finance.yahoo.com/news/chinese-drugmaker-asymchem-slips-hong-020055996.html\">网页链接</a>\n\n</div>\n","source":"lsy1612507957220","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Chinese Drugmaker Asymchem Slips in Hong Kong Trading Debut</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nChinese Drugmaker Asymchem Slips in Hong Kong Trading Debut\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-10 10:55 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/chinese-drugmaker-asymchem-slips-hong-020055996.html><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>(Bloomberg) -- Chinese contract drug manufacturer Asymchem Laboratories Tianjin Co. dropped in its first day of trading in Hong Kong, after completing the Asian financial hub’s biggest initial public ...</p>\n\n<a href=\"https://finance.yahoo.com/news/chinese-drugmaker-asymchem-slips-hong-020055996.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"06821","symbol_name":"凯莱英","start_time":0,"source_url":"https://finance.yahoo.com/news/chinese-drugmaker-asymchem-slips-hong-020055996.html","article_id":"1118435301","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1118435301","pubTimestamp":1639104912,"sourceInfo":{"source_id":"lsy1612507957220","name":"finance.yahoo"},"weMediaInfo":null,"summary":"(Bloomberg) -- Chinese contract drug manufacturer Asymchem Laboratories Tianjin Co. dropped in its f","collect":0,"end_time":0,"defaultTopTitle":"yahoo.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"06821":"凯莱英"},"translate_title":"中国制药商Asymchem在香港上市","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"06821":0.9},"content_text":"(Bloomberg) -- Chinese contract drug manufacturer Asymchem Laboratories Tianjin Co. dropped in its first day of trading in Hong Kong, after completing the Asian financial hub’s biggest initial public offering in more than two months.\nThe shares fell as much as 4.5% to HK$370.40 on Friday. They were sold at HK$388 apiece in an IPO that raised about HK$7.15 billion ($917 million). The H-shares had been marketed at between HK$350 and HK$410 and were ultimately priced at a discount of 34% to Asymchem’s Shenzhen-listed stock.\nAsymchem is the largest IPO in Hong Kong since Dongguan Rural Commercial Bank Co.’s $1.2 billion deal in September. Hong Kong’s exchange has hosted few large offerings in recent months as Beijing’s clampdowns on various industries soured sentiment in both the primary and secondary markets.\nTwelve of 16 IPOs in the city since August raising over $100 million each ended their first session below their listing price, according to data compiled by Bloomberg as of Thursday.\nAsymchem, a Tianjin-based contract development and manufacturing organization (CDMO) for the drug industry, plans to use proceeds to add capacity and capabilities as well as increase market share. Goldman Sachs Group Inc. and Citic Securities Co. were joint sponsors for the share sale.\nTwo other smaller debuts in Hong Kong on Friday had mixed performance. Gushengtang Holdings Ltd., a traditional Chinese medicine healthcare service provider, jumped as much as 18% following a $104 million offering. CANbridge Pharmaceuticals Inc., a biopharmaceutical company, dropped as much as 29% following an $88 million IPO.","kind":null,"is_publish_news":true,"is_publish_highlight":true,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":605957478,"gmtCreate":1639105059805,"gmtModify":1639106292443,"author":{"id":"3555327015224476","authorId":"3555327015224476","name":"rustic","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":1,"crmLevelSwitch":0},"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/605957478","repostId":1118435301,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":6922751,"gmtCreate":1639106040225,"gmtModify":1639106040317,"authorId":3575454990112554,"author":{"id":3575454990112554,"authorId":3575454990112554,"name":"Bubble5728","avatar":"https://static.tigerbbs.com/ffe6f8385b6f65785cb6f3337622382d","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":605957478,"type":1,"supId":0,"prevId":0,"content":"Ok","text":"Ok","html":"Ok"}],"langContent":"CN"}],"isCommentEnd":false,"newsSizeData":{"likeSize":27,"commentSize":1,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.26.2","shortVersion":"4.26.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1118435301"}